Literature DB >> 11247894

Modulation of colonic barrier function by the composition of the commensal flora in the rat.

A García-Lafuente1, M Antolín, F Guarner, E Crespo, J R Malagelada.   

Abstract

BACKGROUND AND AIMS: Altered intestinal permeability is a key pathogenetic factor of idiopathic bowel inflammation. We investigated in the rat if changes in the composition of the bowel flora can alter colonic permeability.
METHODS: A colonic segment was surgically excluded from faecal transit and brought out as a loop to the abdominal wall through two colostomies. The loop was used for colonisation with specific bacterial strains after eradication of the native flora with antibiotics. Lumen to blood clearance of dextran (molecular weight 70 000) and mannitol (molecular weight 182) was measured in rats recolonised with a single bacterial strain from rat colonic origin, and in control rats whose colonic loop was kept free of bacteria by antibiotics. Actual colonisation was confirmed by culture of segment effluents.
RESULTS: Colonisation with Escherichia coli, Klebsiella pneumoniae, and Streptococcus viridans significantly increased lumen to blood clearance of mannitol. Colonisation with Lactobacillus brevis had the opposite effect and reduced permeability to mannitol. Bacteroides fragilis did not induce significant changes. Permeability to dextran was not altered by any of the strains tested.
CONCLUSIONS: Certain commensal bacteria can modify colonic wall permeability to luminal substances.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11247894      PMCID: PMC1728242          DOI: 10.1136/gut.48.4.503

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

Review 1.  Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes.

Authors:  P Brandtzaeg; T S Halstensen; K Kett; P Krajci; D Kvale; T O Rognum; H Scott; L M Sollid
Journal:  Gastroenterology       Date:  1989-12       Impact factor: 22.682

2.  Hapten-induced model of chronic inflammation and ulceration in the rat colon.

Authors:  G P Morris; P L Beck; M S Herridge; W T Depew; M R Szewczuk; J L Wallace
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

Review 3.  Intestinal permeability: an overview.

Authors:  I Bjarnason; A MacPherson; D Hollander
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

Review 4.  The hydrophobic barrier properties of gastrointestinal mucus.

Authors:  L M Lichtenberger
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

5.  Enteropathogenic Escherichia coli adherence to intestinal epithelial monolayers diminishes barrier function.

Authors:  J Spitz; R Yuhan; A Koutsouris; C Blatt; J Alverdy; G Hecht
Journal:  Am J Physiol       Date:  1995-02

6.  Surface hydrophobicity of the rat colonic mucosa is a defensive barrier against macromolecules and toxins.

Authors:  A Lugea; A Salas; J Casalot; F Guarner; J R Malagelada
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

7.  Bacteroides fragilis toxin 2 damages human colonic mucosa in vitro.

Authors:  M Riegler; M Lotz; C Sears; C Pothoulakis; I Castagliuolo; C C Wang; R Sedivy; T Sogukoglu; E Cosentini; G Bischof; W Feil; B Teleky; G Hamilton; J T LaMont; E Wenzl
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

8.  The effect of dexamethasone administration on rat intestinal permeability: the role of bacterial adherence.

Authors:  J Spitz; G Hecht; M Taveras; E Aoys; J Alverdy
Journal:  Gastroenterology       Date:  1994-01       Impact factor: 22.682

9.  Intestinal permeability and the prediction of relapse in Crohn's disease.

Authors:  J Wyatt; H Vogelsang; W Hübl; T Waldhöer; H Lochs
Journal:  Lancet       Date:  1993-06-05       Impact factor: 79.321

10.  Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats.

Authors:  E Isolauri; H Majamaa; T Arvola; I Rantala; E Virtanen; H Arvilommi
Journal:  Gastroenterology       Date:  1993-12       Impact factor: 22.682

View more
  41 in total

1.  Early enteral feeding and nosocomial sepsis in very low birthweight infants.

Authors:  O Flidel-Rimon; S Friedman; E Lev; A Juster-Reicher; M Amitay; E S Shinwell
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-07       Impact factor: 5.747

Review 2.  Do probiotics have a therapeutic role in gastroenterology?

Authors:  Jimmy K Limdi; Catherine O'Neill; John McLaughlin
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

3.  Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation.

Authors:  Mélanie G Gareau; Jennifer Jury; Glenda MacQueen; Philip M Sherman; Mary H Perdue
Journal:  Gut       Date:  2007-03-05       Impact factor: 23.059

Review 4.  A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action.

Authors:  Esther Swee Lan Chong
Journal:  World J Microbiol Biotechnol       Date:  2013-09-26       Impact factor: 3.312

5.  Enterocyte cytoskeleton changes are crucial for enhanced translocation of nonpathogenic Escherichia coli across metabolically stressed gut epithelia.

Authors:  Aisha Nazli; Arthur Wang; Oren Steen; David Prescott; Jun Lu; Mary H Perdue; Johan D Söderholm; Philip M Sherman; Derek M McKay
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

6.  How can probiotics and prebiotics impact mucosal immunity?

Authors:  Sarah O'Flaherty; Delphine M Saulnier; Bruno Pot; James Versalovic
Journal:  Gut Microbes       Date:  2010-07-07

7.  Effects of Lactobacillus salivarius 433118 on intestinal inflammation, immunity status and in vitro colon function in two mouse models of inflammatory bowel disease.

Authors:  Linda M Feighery; Philip Smith; Liam O'Mahony; Padraic G Fallon; David J Brayden
Journal:  Dig Dis Sci       Date:  2007-12-20       Impact factor: 3.199

8.  Using a mathematical model to analyze the role of probiotics and inflammation in necrotizing enterocolitis.

Authors:  Julia C Arciero; G Bard Ermentrout; Jeffrey S Upperman; Yoram Vodovotz; Jonathan E Rubin
Journal:  PLoS One       Date:  2010-04-19       Impact factor: 3.240

9.  Protective effect of octreotide and infliximab in an experimental model of indomethacin-induced inflammatory bowel disease.

Authors:  Dídia H Bismara Cury; José Edson Costa; Kioshi Irika; Luciana Mijji; Alessandre Garcez; Carlos Buchiguel; Ivani Silva; Aytan Sipahi
Journal:  Dig Dis Sci       Date:  2008-03-20       Impact factor: 3.199

Review 10.  Gut microbiome and metabolic diseases.

Authors:  Shinji Fukuda; Hiroshi Ohno
Journal:  Semin Immunopathol       Date:  2013-11-06       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.